Aslan Fred: insider trades.
Aslan Fred reported 4 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($947K), across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 2
- Companies
- 1
- Name as filed
- Aslan Fred
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | Director, Officer · Chief Executive Officer | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-15 | Artiva Biotherapeutics, Inc. | A | 110,000 | $0 | 1,604,765 | Form 4 |
| 2026-09-10 | Artiva Biotherapeutics, Inc. | A | 45,000 | $0 | 1,494,765 | Form 4 |
| 2026-09-08 | Artiva Biotherapeutics, Inc. | S | 23,429 | $10.92 | 1,449,765 | Form 4 |
| 2026-09-03 | Artiva Biotherapeutics, Inc. | S | 61,888 | $11.16 | 1,473,194 | Form 4 |
Questions
What stock did Aslan Fred buy or sell?
Aslan Fred reported 4 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($947K), across 1 company.
Is Aslan Fred the same person as other filers with this name?
This page covers SEC CIK 1909362 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/aslan-fred-1909362.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.